clinical development comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-02-28. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
| Property | Value | Notes |
|---|---|---|
| Solubility | Soluble in dimethyl sulfoxide and some organic solvents; practically insoluble in water | Solvent choice affects laboratory handling |
| Typical storage | -20 °C, desiccated, protected from light | Common condition for research samples |
| Analytical method | Liquid chromatography–tandem mass spectrometry (LC-MS/MS) | Used for identification and quantification in biological or product samples |
| Common synonyms | GW501516, GW-501516, GSK-516, Endurobol | Names found in research and anti-doping literature |
| Regulatory status | Unapproved therapeutic; prohibited in competitive sport | Status can vary by country and context |
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
Hyōjun (標準): standard grade, contains more than 1.2% total nitrogen Jōkyū (上級): upper grade, contains more than 1.35% of total nitrogen Tokkyū (特級): special grade, contains more than 1.5% of total nitrogen
== Other uses == Opus (mythology), a son of Zeus Opus, Greece, a city in ancient Locris, Greece Opus (Elis), a town in ancient Elis, Greece Opus (architecture), generic term for "construction method", "construction material", "masonry", in use in Ancient Rome OPUS (chromatography), a line of chromatography columns manufactured by Repligen Corporation OPUS (psychiatry), a Danish early intervention program for people with schizophrenia spectrum disorders Opus Film, a Polish film production company
After the malaise of the late 1920s and early 1930, the 1933 season proved a turning point in morale despite no finals entries for the entire 1930s. Essendon saw the debut of the player regarded as one of the game's greatest-ever players, Dick Reynolds. His impact was immediate. He won his first Brownlow Medal aged 19. His record of three Brownlow victories (1934, 1937, 1938), equalled Fitzroy's Haydn Bunton, Sr (1931, 1932, 1935), and later equalled by Bob Skilton (1959, 1963, 1968), and Ian Stewart (1965, 1966, 1971). Reynolds was appointed coach, jointly with Harry Hunter, in 1939 while still a player. A year later, he became the sole coach and led the side into the finals in 1940 for the first time since 1926, finishing third. Melbourne defeated Essendon by 5 points in the preliminary final and went on to win the premiership. The Essendon Football Club adopted the nickname The Bombers in April 1940. The 1941 season culminated in Essendon's first grand final appearance since 1923, but the side again lowered its colours to Melbourne. While Australia had entered World War II – located primarily in Europe and Africa – in 1939, the Pacific Theatre opened in December 1941. Australian sports competition was considerably weakened, with Geelong being forced to pull out of the competition due to petrol rationing. Attendances at games also declined dramatically, while some clubs had to move from their normal grounds due to them being used for military purposes. Many players were lost to football due to their military service.
Sources: en.wikipedia.org
=== Club records in UEFA competitions === As of 27 August 2026 Biggest win in UEFA competition: 9 November 2023, Freiburg 5–0 TSC, at Freiburg 30 November 2023, Freiburg 5–0 Olympiacos, at Freiburg Biggest defeat in UEFA competition: 14 March 2024, West Ham United 5–0 Freiburg, at London Club appearances in UEFA Europa League: 7 Player with most UEFA appearances: Matthias Ginter – 39 appearances Top scorer in UEFA club competitions: Vincenzo Grifo – 11 goals
== History == The wild ancestor of common buckwheat is F. esculentum ssp. ancestrale. F. homotropicum is interfertile with F. esculentum and the wild forms have a common distribution, in Yunnan, a southwestern province of China. The wild ancestor of tartary buckwheat is F. tataricum ssp. potanini. Common buckwheat was domesticated and first cultivated in inland Southeast Asia, possibly around 6000 BC, and from there spread to Central Asia and Tibet, and then to the Middle East and Europe, which it reached by the 15th century. Domestication most likely took place in the western Yunnan region of China. The oldest remains found in China so far date to c. 2600 BC, while buckwheat pollen found in Japan dates from as early as 4000 BC. It is the world's highest-elevation domesticate, being cultivated in Yunnan on the edge of the Tibetan Plateau or on the plateau itself. Buckwheat was one of the earliest crops introduced by Europeans to North America. Dispersal around the globe was complete by 2006, when a variety developed in Canada was widely planted in China. In India, buckwheat flour is known as kuttu ka atta and has long been culturally associated with many festivals like Shivratri, Navaratri and Janmashtami. On the day of these festivals, food items made only from buckwheat are consumed.
Such was the likelihood of Manchester United going on to retain the title, bookmaker Fred Done paid out on punters with two months of the season left. Arsenal steadily closed the gap, however, and victory against Wimbledon in March 1998 set up a title clash between themselves and the reigning champions. Wenger in the lead up to the game maintained it was possible for Arsenal to win the league, stating "two or three weeks ago, the title was just a dream for us and people laughed when I said we could still do it". He suggested Manchester United were responsible for making the title race "interesting". At Old Trafford, Overmars scored the decisive goal to give Arsenal a 1–0 win. The victory was followed by nine consecutive league wins, the last of which was a home fixture against Everton that secured Arsenal's status as champions. Wenger became the first foreign manager to win the double, when his team beat Newcastle United in the 1998 FA Cup Final. Wenger sanctioned Wright's transfer to West Ham in the summer and made Anelka his first-choice striker ahead of the 1998–99 season. His decision not to bolster Arsenal's attack, coupled with Bergkamp's fear of flying, meant the club entered the Champions League with just one recognised striker. Their time in the competition was brief, making an exit at the group stage, with their domestic form being indifferent. Needing to strengthen their attacking options, Arsenal signed Nwankwo Kanu in January 1999, and his presence reinvigorated the team as they embarked on a run similar to last season.
=== Third week (7–13 March) === On 7 March, Pakistani officials stated that they had carried out air strikes along the Pakistan-Afghanistan border, destroying several Afghan Taliban positions. The officials added the airstrikes inflicted heavy casualties on the Taliban forces, forcing them to abandon and flee from those positions. Meanwhile, Taliban officials said that Pakistani forces had bombed the provinces of Paktia, Paktika, Khost, Maidan Wardak, and Kunar, resulting in civilian casualties and damage to homes and shops. Taliban officials did not comment on the casualties suffered by their forces. Taliban officials also urged the United Nations Security Council (UNSC) to take action to stop Pakistan's attacks. They cited recent strikes on several Afghan provinces, civilian casualties, displacement, and the expulsion and harassment of Afghan refugees in Pakistan, and called on the UNSC to help end the situation. Taliban officials in Torkham border crossing area said that Pakistan's attacks have destroyed at least 150 shops, resulting heavy financial losses for Afghan business owners. In Nangarhar province, residents state that the Taliban had forced them to participate in a protest against Pakistan in Jalalabad, in some cases by offering cash payments. Three Policemen were killed and 31 people including five Policemen and 26 civilians were wounded in an IED attack targeting a police patrol in Wana. A drone attack on relatives of police peace committee killed two and wounded seven in Lakki Marwat District while a bomb blast killed two more civilians and wounded ten.
Sources: en.wikipedia.org
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.
No. It is not an anabolic-androgenic steroid; it is a synthetic PPARδ agonist. Because it is banned in sport, it is sometimes grouped with doping agents even though its chemical class differs from steroids.
Human data are limited and development was discontinued, so major effects and long-term risks are not well characterized. Some early studies examined metabolic markers, but they do not provide a basis for unsupervised use.
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.